Effects of physical training on IL-1p, IL-6 and IL-lra concentrations in various brain areas of the rat

European Cytokine Network

Volumn 19, Issue 1, 2008, Pages 8-14

  Chennaoui, Mounir ^a   Drogou, Catherine ^a   Gomez Merino, Danielle ^a  

^a Institut de Medecine Aerospatiale du Service de Sante des Armees   (France)

Author keywords

Brain; Cytokines; Exercise training; Rat

Indexed keywords

BRAIN PROTEIN; CORTICOSTERONE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; PROLACTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CEREBELLUM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; FRONTAL CORTEX; HIPPOCAMPUS; HYPOPHYSIS; HYPOTHALAMUS; MALE; MUSCLE TRAINING; NONHUMAN; PHYSICAL ACTIVITY; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RAT; SITTING; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; BLOOD; BODY WEIGHT; BRAIN; METABOLISM; TISSUE DISTRIBUTION; WISTAR RAT;

RATTUS;

ANIMALS; BODY WEIGHT; BRAIN; CEREBELLUM; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEPTIN; MALE; MODELS, BIOLOGICAL; PHYSICAL CONDITIONING, ANIMAL; PITUITARY GLAND; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 55749105157     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2008.0115     Document Type: Article

References (46)

1. Albeck DS, Sano K, Prewitt GE, Dalton L. Mild forced treadmill exercise enhances spatial learning in the aged rat. Behav Brain Res 2006; 168: 345.
2. Anderson BJ, Rapp DN, Baek DH, McCloskey DP, Coburn-Litvak PS, Robinson JK. Exercise influences spatial learning in the radial arm maze. Physiol Behav 2000; 70: 425.
3. Radak Z, Sasvari M, Nyakas C, Kaneko T, Tahara S, Ohno H, Goto S. Single bout of exercise eliminates the immobilization-induced oxidative stress in rat brain. Neurochem Int 2001; 39: 33.
4. Spirduso WW, Farrar RP. Effects of aerobic training on reactive capacity: an animal model. J Gerontol 1981; 36: 654.
5. Skalicky M, Bubna-Littitz H, Viidik A. Influence of physical exercise on aging rats: I. Life-long exercise preserves patterns of spontaneous activity. Mech Ageing Dev 1996; 87: 127.
6. Wang RY, Yang YR, Yu SM. Protective effects of treadmill training on infarction in rats. Brain Res 2001; 922: 140.
7. Trejo JL, Carro E, Torres-Aleman I. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J Neurosci 2001; 21: 1628.
8. Cotman CW, Berchtold NC. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 2002; 25: 295.
9. Ang ET, Wong PT, Moochhala S, Ng YK. Neuroprotection associated with running: is it a result of increased endogenous neu-rotrophic factors? Neuroscience 2003; 118: 335.
10. Tong L, Balazs R, Soiampornkul R, Thangnipon W, Cotman CW. Interleukin-1beta impairs brain derived neurotrophic factor-induced signal transduction. Neurobiol Aging 2007 (in press).
11. Gomez-Merino D, Drogou C, Guezennec CY, et al. Comparison of systemic cytokine responses after a long distance triathlon and a 100-kmrun: relationship to metabolic and inflammatory processes. Eur Cytokine Netw 2006; 17: 117.
12. Fischer CP, Plomgaard P, Hansen AK, Pilegaard H, Saltin B, Ped-ersen BK. Endurance training reduces the contraction-induced interleukin-6 mRNA expression in human skeletal muscle. Am J Physiol Endocrinol Metab 2004; 287: E1189.
13. Ding YH, Young CN, Luan X, et al. Exercise preconditioning ameliorates inflammatory injury in ischemic rats during reperfusion. Acta Neuropathol (Berl) 2005; 109: 237.
14. Tidball JG. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol 2005; 288: R345.
15. Dantzer R. Cytokine-induced sickness behaviour: a neuro-immune response to activation of innate immunity. Eur J Pharmacol 2004; 500: 399.
16. Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 1992; 263: C1.
17. Maher FO, Clarke RM, Kelly A, Nally RE, Lynch MA. Interaction between interferon gamma and insulin-like growth factor-1 in hippocampus impacts on the ability of rats to sustain long-term potentiation. J Neurochem 2006; 96: 1560.
18. Nelson TE, Ur CL, Gruol DL. Chronic interleukin-6 exposure alters electrophysiological properties and calcium signalling in developing cerebellar Purkinje neurons in culture. J Neurophysiol 2002; 88: 475.
19. Baldwin KM, Cooke DA, Cheadle WG. Time course adaptations in cardiac and skeletal muscle to different running programs. J Appl Physiol 1977; 42: 267.
20. Chennaoui M, Gomez Merino D, Lesage J, Drogou C, Guezennec CY. Effects of moderate and intensive training on the hypothalamo-pituitary-adrenal axis in rats. Acta Physiol Scand 2002; 175:113.
21. 21.Lynch AM, Lynch MA. The age-related increase in IL-1 type I receptor in rat hippocampus is coupled with an increase in caspase-3 activation. Eur J Neurosci 2001; 15: 1779.
22. Griffin WS, Sheng JG, Roberts GW, MrakRE. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol 1995; 54: 276.
23. Farmer J, Zhao X, van Praag H, Wodtke K, Gage FH, Christie BR. Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male Sprague-Dawley rats in vivo. Neuroscience 2004; 124: 71.
24. Lynch MA. Long-term potentiation and memory. Physiol Rev 2004; 84: 87.
25. Hirano T. The biology of interleukin-6. Chem Immunol 1992; 51: 153.
26. Gadient RA, Otten U. Identification of interleukin-6 (IL-6)- expressing neurons in the cerebellum and hippocampus of normal adult rats. Neurosci Lett 1994; 182: 243.
27. Cacquevel M, Lebeurrier N, Cheenne S, Vivien D. Cytokines in neuroinflammation and Alzheimer's disease. Curr Drug Targets 2004; 5: 529.
28. Smith CJ, Emsley HC, Gavin CM, et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 2004; 4: 2.
29. Campbell IL, Abraham CR, Masliah E, et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 1993; 90: 10061.
30. Deb S, Tessier C, Prigent-Tessier A, et al. The expression of interleukin-6 (IL-6), IL-6 receptor, and gp130-kilodalton glycoprotein in the rat decidua and a decidual cell line: regulation by 17beta-estradiol and prolactin. Endocrinology 1999; 140: 4442.
31. Motta M, Accornero P, Baratta M. Leptin and prolactin modulate the expression of SOCS-1 in association with interleukin-6 and tumor necrosis factor-alpha in mammary cells: a role in differentiated secretory epithelium. Regul Pept 2004; 121: 163.
32. Starr R, Willson TA, Viney EM, et al. A family of cytokineinducible inhibitors of signalling. Nature 1997; 387: 917.
33. Hannum CH, Wilcox CJ, Arend WP, et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 1990; 343: 336.
34. Poutsiaka DD, Clark BD, Vannier E, Dinarello CA. Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated. Blood 1991; 78: 1275.
35. Allan SM. The role of pro- and anti-inflammatory cytokines in neurodegeneration. Ann N Y Acad Sci 2000; 917: 84.
36. Gayle D, Ilyin SE, Flynn MC, Plata-Salaman CR. Lipopolysaccharide (LPS)- and muramyl dipeptide (MDP)-induced anorexia during refeeding following acute fasting: characterization of brain cytokine and neuropeptide systems mRNAs. Brain Res 1998;795: 77.
37. Gabellec MM, Crumeyrolle-Arias M, Le Saux F, Auriou N, Jacque C, Haour F. Expression of interleukin-1 genes and interleukin-1 receptors in the mouse brain after hippocampal injury. Neurosci Res 1999; 33: 251.
38. 38.Pinteaux E, Rothwell NJ, Boutin H. Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-lra) are mediated by glia. Glia 2006; 53: 551.
39. PeltolaJ, Palmio J, KorhonenL et al. Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res 2000; 41: 205.
40. Relton D, Relton JK, Miller G, Bendele A, Fischer N, Russel D. Cytokines as therapeutic agents in neurological disorders. In: Rothwell N, ed. Cytokines in the Nervous System. New York: Chapman and Hall, 1996: 163.
41. Garcia JH, Liu KF, Relton JK. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol 1995; 147: 1477.
42. Sauer J, Arzt E, Gumprecht H, Hopfner U, Stalla GK. Expression of interleukin-1 receptor antagonist in human pituitary adenomas in vitro. J Clin Endocrinol Metab 1994; 79: 1857.
43. Gomez-Merino D, Chennaoui M, Drogou C, Bonneau D, Guezennec CY. Decrease in serum leptin after prolonged physical activity in men. Med Sci Sports Exerc 2002; 34: 1594.
44. Gomez-Merino D, Drogou C, Guezennec CY, Chennaoui M. Effects of chronic exercise on cytokine production in white adipose tissue and skeletal muscle of rats. Cytokine 2007; 40: 23.
45. Flier JS. Leptin expression and action: new experimental paradigms. Proc Natl Acad Sci USA 1997; 94: 4242.
46. Hosoi T, Okuma Y, Nomura Y. Leptin induces IL-1 receptor antagonist expression in the brain. Biochem Biophys Res Commun 2002; 294: 215-9.s 47. Hosoi T, Okuma Y, Nomura Y. Leptin regulates interleukin-1beta expression in the brain via the STAT3-independent mechanisms. Brain Res 2002; 949: 139.